A recent study has shown that the actin cytoskeleton regulated by ANXA2 has a negative effect on T cell aggregation, which may be one of the mechanisms by which upregulation of ANXA2 expression in tumors leads to reduced T cell activation and immune imbalance in the tumor microenvironment26. Here, ANXA2 is linked to neoplasm.